Literature DB >> 11762999

Regulatory issues in Europe.

C Barbui, G Guaiana, S Garattini.   

Abstract

Mesh：

Year:  2001        PMID： 11762999     DOI： 10.1097/00004714-200112000-00001

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  3 in total

1.  Varying and "atypical" indications for atypical antipsychotics.

Authors:  Corrado Barbui; Michele Tansella; Silvio Garattini
Journal:  Psychopharmacology (Berl)       Date:  2003-05-22       Impact factor: 4.530

2.  CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation?

Authors:  Corrado Barbui; Andrea Cipriani; Camilla Lintas; Vittorio Bertelé; Silvio Garattini
Journal:  Psychopharmacology (Berl)       Date:  2006-11-22       Impact factor: 4.530

3.  Development of a registry for monitoring psychotropic drug prescriptions: aims, methods and implications for ordinary practice and research.

Authors:  Corrado Barbui; Michela Nosè; Gianluca Rambaldelli; Chiara Bonetto; Deborah Levi; Scott B Patten; Michele Tansella
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.